Brain

Lace AI Pro Expands Clinical Excellence with Acquisition of Amptify

GAINESVILLE, Fla., Dec. 4, 2024 /PRNewswire/ -- Neurotone AI, pioneer in aural rehabilitation, and creator of Lace AI Pro, today…

1 year ago

Lace AI Pro Expands Clinical Excellence with Acquisition of Amptify

GAINESVILLE, Fla., Dec. 4, 2024 /PRNewswire/ -- Neurotone AI, pioneer in aural rehabilitation, and creator of Lace AI Pro, today…

1 year ago

Boland Romaine LLP is Happy to Announce the Launch of it’s New Website to Better Serve Ontario’s Residents

Redefining Advocacy for the Injured and The Unsettling Truth About SettlingTORONTO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- In an effort…

1 year ago

NeuroOne® to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time

EDEN PRAIRIE, Minn., Dec. 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a…

1 year ago

BioGene Therapeutics Announces Appointment of Dr. Brian Gallagher, Jr. to Corporate Advisory Board

Vancouver, British Columbia--(Newsfile Corp. - December 4, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the…

1 year ago

Sage Growth Partners Announces Marketing and Public Relations Partnership with ChronicCareIQ

Baltimore-based healthcare growth strategy and marketing firm to provide public relations, thought leadership, and digital marketing services   BALTIMORE, Dec.…

1 year ago

OP Media Inc Brings Efficiency to the Health Care Space

Creating OPs, not APPS involves frontline staff in Best Practices SALT LAKE CITY, Dec. 3, 2024 /PRNewswire/ -- Start-up company,…

1 year ago

Dr. Alexander Taghva Introduces Focused Ultrasound Treatment for Essential Tremors in Orange County, CA

Focused Ultrasound Therapy for tremors is now available for patients with Dr. Taghva in Orange County MISSION VIEJO, CAPELLEN /…

1 year ago

Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA

Milestone Reinforces the Potential for Cytisinicline as a First-in-Class Treatment for Vaping CessationSEATTLE and VANCOUVER, British Columbia, Dec. 03, 2024…

1 year ago